Spyre Therapeutics, Inc. · NASDAQ:SYRE

Peter Evan Harwin reported a 9.99% stake in Spyre Therapeutics, Inc. (Schedule 13D/A)

Event Jun 23, 2026 · Filed Jun 23, 2026

Peter Evan Harwin reported a 9.99% stake in Spyre Therapeutics, Inc., 9,667,201 shares, with active intent on Jun 23, 2026. Filed Jun 23, 2026 (Schedule 13D/A).

Stake
9.99%
Shares
9,667,201
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Fairmount Funds Management LLC9.15%8,835,440
Fairmount Healthcare Fund II L.P.9.15%8,835,440
Peter Evan Harwin9.99%9,667,201
Tomas Kiselak9.99%9,667,201

Source

View original at SEC

Related